Device Trial Radar · NCT02412163
Ellipse Intramedullary Nail High Tibial Osteotomy Study
Last checked: Nov 20, 2026Latest source record: Sep 1, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
41
Actual
Start
Jul 2015
Primary completion
Jul 2015
Study completion Dec 2016
Sponsor
- Lead sponsor
- Ellipse Technologies, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 9, 2015
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study further evaluates the safety profile and efficacy of the Ellipse IM HTO Nail system in subjects with osteoarthritis and varus malalignment of the knee. All subjects will receive treatment with the Ellipse IM HTO Nail System and followed for six months.
Conditions
- Osteoarthritis
- Varus Malalignment
Interventions
Ellipse IM HTO NailDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Weight-Bearing Line at Final Correction within ±5, 10, and 15% of Baseline TargetTime frame: Pre-Op, Week 6 (Considered the Final Correction Visit unless additional visits are required)
Locations
11 sites in 4 countries. Site status is shown where the registry gives one.
Medizinische Hochschule
Hanover, Germany
Martini Ziekenhuis
Groningen, Netherlands
Isala Klinieken
Zwolle, Netherlands
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.